Rezolute, Inc. (RZLT)
5.00
-0.09
(-1.77%)
USD |
NASDAQ |
Aug 24, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Rezolute Total Liabilities (Quarterly) : 8.625M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 8.625M |
| December 31, 2025 | 10.63M |
| September 30, 2025 | 11.50M |
| June 30, 2025 | 13.36M |
| March 31, 2025 | 12.17M |
| December 31, 2024 | 12.42M |
| September 30, 2024 | 9.973M |
| June 30, 2024 | 11.73M |
| March 31, 2024 | 16.88M |
| December 31, 2023 | 10.42M |
| September 30, 2023 | 9.435M |
| June 30, 2023 | 7.549M |
| March 31, 2023 | 6.889M |
| December 31, 2022 | 8.943M |
| September 30, 2022 | 2.898M |
| June 30, 2022 | 2.949M |
| March 31, 2022 | 17.67M |
| December 31, 2021 | 21.14M |
| September 30, 2021 | 17.20M |
| June 30, 2021 | 16.51M |
| March 31, 2021 | 3.801M |
| December 31, 2020 | 3.016M |
| September 30, 2020 | 3.028M |
| June 30, 2020 | 3.60M |
| March 31, 2020 | 4.375M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.877M |
| September 30, 2019 | 5.954M |
| June 30, 2019 | 10.50M |
| March 31, 2019 | 10.81M |
| December 31, 2018 | 10.24M |
| September 30, 2018 | 7.512M |
| June 30, 2018 | 6.464M |
| March 31, 2018 | 4.608M |
| December 31, 2017 | 2.520M |
| September 30, 2017 | 1.991M |
| June 30, 2017 | 2.101M |
| March 31, 2017 | 2.335M |
| December 31, 2016 | 2.006M |
| September 30, 2016 | 1.854M |
| June 30, 2016 | 2.130M |
| March 31, 2016 | 2.850M |
| December 31, 2015 | 2.953M |
| September 30, 2015 | 2.413M |
| June 30, 2015 | 2.209M |
| March 31, 2015 | 2.352M |
| December 31, 2014 | 2.906M |
| September 30, 2014 | 1.248M |
| June 30, 2014 | 0.9979M |
| March 31, 2014 | 2.862M |
| December 31, 2013 | 6.543M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 7.726M |
| AbbVie, Inc. | 141.00B |
| Marker Therapeutics, Inc. | 2.42M |
| Avalo Therapeutics, Inc. | 42.12M |
| Krystal Biotech, Inc. | 141.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.46M |
| Shareholders Equity (Quarterly) | 116.83M |
| Debt to Equity Ratio | 0.0095 |
| Current Ratio | 15.84 |
| Net Debt Paydown Yield | 0.06% |